Efficacy and tolerability of interferon (Intron a) plus ribavirin (Rebetron) administered daily for two months, then thrice weekly interferon (Intron a) plus ribavirin (Rebetron), versus standard thrice weekly administration of Rebetron for the treatment of chronic hepatitis C in patients naive to interferon therapy

✍ Scribed by Michael S. Epstein; Teresa DeHaemer; Patricia M. Praschak; Robert G. Finkel; Natarajan Ravendhran; Ira F. Lobis; Louis Yves Korman; Ryan P. Crenshaw; Nicholas D. Snow; Jacqueline Laurin

• Book ID: 119391226
• Publisher: Nature Publishing Group
• Year: 2001
• Tongue: English
• Weight: 22 KB
• Volume: 96
• Category: Article
• ISSN: 0002-9270
• DOI: 10.1016/s0002-9270(01)03116-1